EXPRESSION OF MHC CLASS-II DETERMINANTS BY JEJUNAL EPITHELIUM IN CELIAC-DISEASE

被引:2
|
作者
SCOTT, H
SOLLID, LM
BRANDTZAEG, P
机构
关键词
D O I
10.1097/00005176-198801000-00027
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:145 / 146
页数:2
相关论文
共 50 条
  • [41] PERFORATION OF A JEJUNAL ADENOCARCINOMA COMPLICATING CELIAC-DISEASE
    MAGNUSSEN, PA
    GRANT, JW
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1986, 79 (02) : 114 - 115
  • [42] RHEUMATOID LYMPHOCYTE-T MHC CLASS-II EXPRESSION - INVITRO STIMULATION PRODUCES NORMAL MHC CLASS-II EXPRESSION, INDEPENDENT OF PROLIFERATION
    KIRKHAM, BW
    PITZALIS, C
    KINGSLEY, GH
    TIMMS, AM
    KYRIAZIS, N
    PANAYI, GS
    JOURNAL OF RHEUMATOLOGY, 1989, 16 (03) : 270 - 275
  • [43] EVIDENCE FOR EXPRESSION OF CLASS-II MHC PUBLIC DETERMINANTS DETECTED BY T-CELL CLONES
    NIKAEIN, A
    MCQUEEN, K
    GOBELI, M
    TRANSPLANTATION PROCEEDINGS, 1989, 21 (01) : 626 - 627
  • [44] JEJUNAL RETICULOSARCOMA COMPLICATING CELIAC-DISEASE IN ADULT
    CAPRON, JP
    MARTI, R
    DELAMARRE, J
    NOUVELLE PRESSE MEDICALE, 1976, 5 (02): : 80 - 82
  • [45] INSITU JEJUNAL SURFACE PH IN CELIAC-DISEASE
    LUCAS, ML
    RAWLINGS, JM
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1984, 8 (11): : 869 - 869
  • [46] ABNORMAL EXPRESSION OF CLASS-II MHC ANTIGENS IN PLACENTAE FROM PATIENTS WITH PEMPHIGOID GESTATIONIS - ANALYSIS OF CLASS-II MHC SUBREGION PRODUCT EXPRESSION
    BORTHWICK, GM
    HOLMES, RC
    STIRRAT, GM
    PLACENTA, 1988, 9 (01) : 81 - 94
  • [47] GAMMA/DELTA T-CELL RECEPTOR EXPRESSION IN THE JEJUNAL EPITHELIUM OF PATIENTS WITH DERMATITIS-HERPETIFORMIS AND CELIAC-DISEASE
    STURGESS, R
    KONTAKOU, M
    NELUFER, J
    HUNG, T
    CICLITIRA, PJ
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1993, 18 (04) : 318 - 321
  • [48] MHC CLASS-II REGULATION - LESSONS FROM A DISEASE
    MACH, B
    NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (02): : 120 - 122
  • [49] CELIAC-DISEASE AMONG ASHKENAZI JEWS FROM ISRAEL - A STUDY OF THE HLA CLASS-II ALLELES AND THEIR ASSOCIATIONS WITH DISEASE SUSCEPTIBILITY
    TIGHE, MR
    HALL, MA
    ASHKENAZI, A
    SIEGLER, E
    LANCHBURY, JS
    CICLITIRA, PJ
    HUMAN IMMUNOLOGY, 1993, 38 (04) : 270 - 276
  • [50] ABROGATION OF TUMORIGENICITY BY MHC CLASS-II ANTIGEN EXPRESSION REQUIRES THE CYTOPLASMIC DOMAIN OF THE CLASS-II MOLECULE
    OSTRANDROSENBERG, S
    ROBY, CA
    CLEMENTS, VK
    JOURNAL OF IMMUNOLOGY, 1991, 147 (07): : 2419 - 2422